相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Parathormone levels are independently associated with the presence of left ventricular hypertrophy in patients with coronary artery disease
A. Acena et al.
JOURNAL OF NUTRITION HEALTH & AGING (2016)
Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors
Ana Maria Pello et al.
JOURNAL OF CARDIOLOGY (2015)
Associations of Fibroblast Growth Factor-23 with Markers of Inflammation, Insulin Resistance and Obesity in Adults
Lynae J. Hanks et al.
PLOS ONE (2015)
Plasma Fibroblast Growth Factor 23, Parathyroid Hormone, 25-Hydroxyvitamin D3, and Risk of Heart Failure: A Prospective, Case-Cohort Study
Romina di Giuseppe et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
Julia J. Scialla et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease
Julia J. Scialla et al.
NATURE REVIEWS NEPHROLOGY (2014)
A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease
Rajiv Agarwal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Fibroblast Growth Factor 23/Klotho Axis in Chronic Kidney Disease
Kosaku Nitta et al.
NEPHRON CLINICAL PRACTICE (2014)
HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease
C. Morgantini et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
Jose Tunon et al.
PLOS ONE (2014)
A preliminary study of the potential role of FGF-23 in coronary calcification in patients with suspected coronary artery disease
Hirofumi Masai et al.
ATHEROSCLEROSIS (2013)
Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients
Shailendra Sharma et al.
CLINICAL NEPHROLOGY (2013)
Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
Johan Arnlov et al.
KIDNEY INTERNATIONAL (2013)
Summary of Recommendation Statements
Adeera Levin et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2013)
Vitamin D in Relation to Myocardial Structure and Function after Eight Years of Follow-Up: The Hoorn Study
A. J. van Ballegooijen et al.
ANNALS OF NUTRITION AND METABOLISM (2012)
25-Hydroxyvitamin D Levels and Risk of Ischemic Heart Disease, Myocardial Infarction, and Early Death Population-Based Study and Meta-Analyses of 18 and 17 Studies
Peter Brondum-Jacobsen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Phosphate: a stealthier killer than previously thought?
Emilio Gonzalez-Parra et al.
CARDIOVASCULAR PATHOLOGY (2012)
Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease A Meta-Analysis of Prospective Studies
Lu Wang et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
Combined Use of Vitamin D Status and FGF23 for Risk Stratification of Renal Outcome
Chikako Nakano et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Impaired Response of FGF-23 to Oral Phosphate in Patients with Type 2 Diabetes: A Possible Mechanism of Atherosclerosis
Koichiro Yoda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: Dependent or independent risk factors?
Jeffrey L. Anderson et al.
AMERICAN HEART JOURNAL (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Vitamin D, Parathyroid Hormone, and Cardiovascular Events Among Older Adults
Bryan Kestenbaum et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
Benjamin D. Parker et al.
ANNALS OF INTERNAL MEDICINE (2010)
Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
Myles Wolf
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients
Mohamed M. Nasrallah et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way
Ilhan Tastan et al.
CARDIOVASCULAR RESEARCH (2009)
Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community
Emil Hagstrom et al.
CIRCULATION (2009)
Relationship between circulating FGF23 and total body atherosclerosis in the community
Majd A. I. Mirza et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Vitamin D deficiency and risk of cardiovascular disease
Thomas J. Wang et al.
CIRCULATION (2008)
Parathyroid hormone and the risk of incident hypertension
Eric N. Taylor et al.
JOURNAL OF HYPERTENSION (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Parathyroid hormone and left ventricular hypertrophy
FN Saleh et al.
EUROPEAN HEART JOURNAL (2003)
分享论文
